Evidence map›Paper›PMID 28121648›Full record

Trial reportJournal of pediatric gastroenterology and nutrition2017

Changes in the Gut Microbiota After Early Administration of Oral Synbiotics to Young Infants in India.

Dinesh S Chandel, Maria E Perez-Munoz, Fang Yu, Robert Boissy, Radhanath Satpathy, Pravas R Misra, Nidhi Sharma, Rama Chaudhry, Sailajanandan Parida, Daniel A Peterson and 2 more

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of pediatric gastroenterology and nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03834415 (Influence of Lactobacillus Reuteri DSM17938 on Early Gut Microbial Colonization in Infants Born by Caesarean Section), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03834415 nacompletednot on this mapstarted 2019, after this paper: background citation

Influence of Lactobacillus Reuteri DSM17938 on Early Gut Microbial Colonization in Infants Born by Caesarean Section: A Double-blinded, Randomized, Placebo-controlled Study

TypeinterventionalSponsorInnovacion y Desarrollo de Estrategias en SaludRan2019 to 2019Enrolled69ConditionsC-sectionArmsLactobacillus reuteri DSM17038, Placebo for Probiotics
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Development and Functions of the Infant Gut Microflora: WesternInternational journal of pediatrics · 2020
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 3 countries.

Dinesh S Chandel*Center for Global Health and Development †Department of Environmental, Agricultural and Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha ‡Department of Food Science and Technology, University of Nebraska, Lincoln, NE §Department of Agriculture, Food Science and Nutrition, University of Alberta, Edmonton, Alberta, Canada ||Department of Biostatistics, College of Public Health ¶Center for Bioinformatics and Systems Biology, University of Nebraska Medical Center, Omaha, NE #Asian Institute of Public Health, Bhubaneswar, Odisha **Department of Microbiology, All India Institute of Medical Sciences, New Delhi ††Department of Pediatrics, Division of Neonatology, SCB Medical College, Cuttack, Odisha, India ‡‡Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD §§Division of Neonatology, Department of Pediatrics, Michigan State University, East Lansing, MI ||||Department of Epidemiology, College of Public Health, University of Nebraska Medical Center, Omaha, NE.
Maria E Perez-Munoz
Fang Yu
Robert Boissy
Radhanath Satpathy
Pravas R Misra
Nidhi Sharma
Rama Chaudhry
Sailajanandan Parida
Daniel A Peterson
Ira H Gewolb
Pinaki Panigrahi
University of Nebraska Medical Center · USAsian Institute of Public Health · INCenter for Global Health · USAll India Institute of Medical Sciences · INJohns Hopkins University · USMichigan State University · USUniversity of Alberta · CA

Funding

Prevention of Infection in Indian NeonatesU01HD040574 · NICHD · UNIVERSITY OF MARYLAND BALTIMORE · PI PANIGRAHI, PINAKI · 2001 to 2006
$3.6M
Prevention of neonatal infection in the Indian community setting using probioticsR01HD053719 · NICHD · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PANIGRAHI, PINAKI · 2007 to 2011
$2.3M
NICHD NIH HHS R01 HD053719NICHD NIH HHS U01 HD040574
6 · The paper itself

Abstract

objectivesThe authors examined the changes in the developing gut microbiota of Indian infants enrolled in a colonization study of an oral synbiotic (Lactobacillus plantarum and fructo-oligosaccharides) preparation.

methodsFrozen stool samples were available from a previously published clinical study of the synbiotic preparation administered daily for 7 days to full-term Indian infants delivered by C-section. 16S rRNA gene sequencing of fecal bacterial community-DNA was done in 11 infants sampled on day 7 and day 60 of life.

resultsAll infants showed changes in bacterial diversity with age. While Firmicutes and Proteobacteria were predominant in all, Actinobacteria and Bacteroidetes were initially low on day 7. In control infants, we observed a significant increase (P = 0.012) in the proportions of Actinobacteria on day 60. In the treated group, during the 60-day period, there was a 10-fold increase in Bacteroidetes, a somewhat smaller increase in Firmicutes, and a reduction in Proteobacteria. Compared to controls, treated infants were increasingly colonized by different Gram-positive genera including Enterococcus, Lactobacillus, and Bifidobacterium. Relatively less known taxa and some unassigned sequence reads added to enriched diversity observed in the treated group.

conclusionsThere was a high level of bacterial diversity among infants examined in the present study. Synbiotic treatment induced an increase in overall taxa and Gram-positive diversity, especially in the first week of life. Changes in the microbiota during early infancy should be used as a rationale for selecting probiotics in diverse clinical settings.

Indexed as

Gastrointestinal MicrobiomeLactiplantibacillus plantarumAdministration, OralAge FactorsCesarean SectionFecesFemaleFollow-Up StudiesHumansIndiaInfantInfant, NewbornMaleOligosaccharidesSynbioticsfructooligosaccharideOligosaccharides

Identifiers

PMID28121648
PMCPMC5524612
OpenAlexW2581785719

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.